Literature DB >> 9104735

Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.

M Farrell1, B Sakić, H Szechtman, J A Denburg.   

Abstract

Neuropsychiatric manifestations are a poorly understood and potentially life-threatening complication of systemic lupus erythematosus (SLE). MRL/lpr mice spontaneously develop a lupus-like syndrome which is similar to the human disease in many respects, including behavioural abnormalities. Our previous findings indicated that the age at which infiltration of immune cells into the choroid plexus is first observed coincides with the appearance of behavioural dysfunction in MRL/lpr mice. This present study quantified leukocyte infiltration in relation to prolonged administration of cyclophosphamide (CY), a treatment effective in preventing some behavioural deficits. Compared to MRL +/+ controls, saline-treated MRL/lpr mice had significantly more CD45-positive cells (leukocytes) and CD45R-positive (B) cells in the choroid plexus and in the brain parenchyma. A six week course of CY (100 mg/kg i.p.) significantly reduced the infiltration of CD45, but not of CD45R-positive cells into the choroid plexus of the MRL/lpr substrain. In addition, the presence of leukocytes correlated positively with measures on one behavioural test (floating in the forced swim test) but not on another test (novel object test). These findings suggest that CY treatment has a differential effect on the infiltration of leukocyte subtypes and strengthen the hypothesis that some abnormal behaviour in MRL/lpr mice may be related to the presence of immunocompetent cells in the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104735     DOI: 10.1177/096120339700600310

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

1.  Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.

Authors:  W G James; P Hutchinson; D C Bullard; M J Hickey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus.

Authors:  Minesh Kapadia; Hui Zhao; Donglai Ma; Boris Sakic
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-11       Impact factor: 4.147

Review 3.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

4.  Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus.

Authors:  Ariel D Stock; Evan Der; Sivan Gelb; Michelle Huang; Karen Weidenheim; Ayal Ben-Zvi; Chaim Putterman
Journal:  JCI Insight       Date:  2019-06-06

5.  Behavioral heterogeneity in an animal model of neuropsychiatric lupus.

Authors:  Boris Sakic; Steven E Hanna; Jason M Millward
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

6.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

7.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

8.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

9.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09

10.  Disturbed distribution of proliferative brain cells during lupus-like disease.

Authors:  Mile Stanojcic; Tal Burstyn-Cohen; Nadia Nashi; Greg Lemke; Boris Sakic
Journal:  Brain Behav Immun       Date:  2009-06-06       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.